Abstract

Presentation given by Kathleen Dooling on November 23rd 2020 to decide on select groups for COVID-19 vaccine allocation in Phase 1a, Phase 1b & Phase 1c

  • Background paper
  • Americas
  • United States of America
  • COVID-19